HIGHLIGHTS OF THE 3rd WORLD CONFERENCE ON BREAST AND CERVICAL CANCER.
The 3rd World Conference on Breast and Cervical Cancer was held in Abu Dhabi, UAE on the 24th and 25th September 2018. It was originally slated for 27th and 28th but was pushed back eventually.
The conference was held to discuss the strides made in the field of Breast and Cervical Cancer with the theme: “Together We Can Make A Difference Against Cancer”. The conference was held in Radisson Blu, Yas Island with experts in the different areas in Breast and Cervical Cancer. The organizing committee was made up of a team of professionals with different fields of interest related to Breast Cancer from different countries ranging from Iran to UAE to the US. They include Mahir Jallo (Gulf Medical University), Marveh Rahmati (Tehran University of Medical Sciences), Feroz Agad (SAH Global Proton Therapy Cancer Treatment), Brianne Joseph (Punk Azz Breast Cancer), Yan-Gao Man (Journal of Cancer) and Swasan A. S. Al Madhi (Friends of Cancer Patients).
The first session of the conference was chaired by the CEO of Monitor Healthcare, Dr. Femi Ogunremi and was Co-Chaired by Wijdan Alomaim, of the Al Mafraq Hospital. The sessions were on Breast Cancer Biology, Breast Reconstruction, Cancer Epigenomics, Immunological Approaches to Cancer Therapy and Cervical Cancer Biology.
There was a lot of networking that went on in addition to the various panel discussions that went on during the conference. There was a talk on the uniting of different stakeholders and facilities involved in the fight against Breast Cancer as a key to winning the fight.
Dr Ogunremi gave his presentation on the “new opportunities and potentials for breast cancer screening on a large scale especially in poor resource areas.” He talked about the high mortality rate in poor resource countries and he lack of adequate knowledge and understanding of breast cancer. He stated that in these poor resource regions, many women don’t know how to conduct self-examination or what to look for when doing the said examination.
He analyzed that these areas need help especially with regards to adequate and consistent screening exercises on a large scale. He suggested this method that can create a huge dent in the rate of breast cancer mortality.
He presented BREAST-i as the revolutionary tool that can get the job done. With the red light technology that is not harmful to the body, the cells absorb the light and reflect any abnormalities. With the various modifications that has been made to the BREAST-i device, it becomes a strong tool that can be used for over 70 – 100 patients when fully charged. The light intensity can be regulated to accommodate different breast densities and has a sensitivity of 96% and a specificity of 87%. The device is battery powered and easy to use.
The conference ended on the 25th September with the presentation of papers, panel discussion, and the closing ceremony. The next World Conference on Breast and Cervical Cancer is set to hold in Helinski, Finland in October 2019.